AI-Powered Medical Affairs: Enhancing value, engagement, and insights
The pharmaceutical sector is witnessing a transformative shift fueled by the…
Unveiling the Financial Ties: HCPs, PAOs and Pharmaceutical Funding
The entanglement of financial relationships among healthcare professionals…
New antibiotics on the way: How pharma can tackle the Antimicrobial Resistance crisis
The overuse and misuse of antimicrobials in humans and animals have escalated…
How Education can serve as a catalyst for wider Biosimilar Adoption.
Even two decades after their introduction, the global adoption rate of…
Navigating the Biosimilar Landscape: What to watch out in 2024 and Beyond
The anticipated expiration of exclusivity rights for major biologics in 2022…
The Next Frontier: Pharma and Longevity
From The Epic of Gilgamesh, the earliest surviving book, to the controversial…
mRNA personalized Cancer Vaccines: BioNTech and Moderna Race to the Finish Line
With the emergence of immunotherapy for oncology, cancer vaccines are cropping…
Cell and Gene Therapy Clinical Trials – 2024 Edition
Gene therapy clinical trials promise transformative breakthroughs in treating…
How we helped an established hemophilia player optimize its market access, pricing and reimbursement strategies in the US and EU5 markets.
The Challenge: How can an established player adapt its market access and…
How LucidQuest helped a company in the hemophilia space enhance its position in the market
The Challenge: How to unveil competitors' plans and gain a strategic edge A…
How LucidQuest Supported a leading pharma in Hemophilia to better position its Hemophilia A assets vs. a key competitor in the US
The Challenge: How can a Top-20 Pharma company uncover the key competitor's…
How a pharma in the digital respiratory space assessed its market positioning and refined its GTM strategy.
The Challenge: How to understand the go-to-market (GTM) strategies of key…